Ethyl Acetate Fraction from Hedyotis Diffusa Plus Scutellaria Barbata Inhibits the Progression of Breast Cancer via Targeting LMO1 and AKT/Mtor Signaling Pathway


Цитировать

Полный текст

Аннотация

Background:Traditional Chinese medicines are widely used in cancer treatment. Scutellaria barbata and Hedyotis diffusa herb pair (SH) has an anticancer effects in various tumors. However, the specific mechanism of SH in breast cancer remains unclear.

Methods:In the present research, we investigated the effect and regulatory network of SH in in breast cancer. CCK8, colony formation, transwell, wound healing and flow cytometry analysis were used for the detection of cell function.

Results:Ethyl acetate fraction from SH at an equal weight ratio (EA11) could inhibit the proliferation, migration and invasion of MCF7 and MDA-MB-231 cells. It also induced apoptosis in these two cell lines by downregulating Bcl2 and upregulating Bax and Cleaved-Caspase3. SH reduced the activation of the AKT/mTOR signaling pathway and the expression of p70S6K. Sequencing results showed that LMO1 was significantly downregulated in SH-treated cells compared with control cells. Importantly, overexpression of LMO1 attenuated the inhibitory effect of SH on cell proliferation and invasion and induced inflammatory tumor microenvironment.

Conclusion:In conclusion, the SH herb pair inhibited the proliferation and metastasis through downregulating LMO1 expression and reducing the activation of the AKT/mTOR signaling pathway. LMO1 has the potential as a new target in the treatment of breast cancer.

Об авторах

Zhiyuan Li

Health Care Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Email: info@benthamscience.net

Jingwei Li

Department of Breast Thyroid Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Email: info@benthamscience.net

Xiaofei Liu

Department of Breast Thyroid Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Email: info@benthamscience.net

Ziyuan Sun

Department of Breast Thyroid Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Email: info@benthamscience.net

Xiaohui Sun

Department of Breast Thyroid Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Автор, ответственный за переписку.
Email: info@benthamscience.net

Список литературы

  1. Anastasiadi, Z.; Lianos, G.D.; Ignatiadou, E.; Harissis, H.V.; Mitsis, M. Breast cancer in young women: An overview. Updates Surg., 2017, 69(3), 313-317. doi: 10.1007/s13304-017-0424-1 PMID: 28260181
  2. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin., 2021, 71(3), 209-249. doi: 10.3322/caac.21660 PMID: 33538338
  3. Fahad Ullah, M. Breast Cancer: Current Perspectives on the Disease Status. Adv. Exp. Med. Biol., 2019, 1152, 51-64. doi: 10.1007/978-3-030-20301-6_4 PMID: 31456179
  4. Liu, Y.T.; Hsiao, C.H.; Tzang, B.S.; Hsu, T.C. In vitro and in vivo effects of traditional Chinese medicine formula T33 in human breast cancer cells. BMC Complement. Altern. Med., 2019, 19(1), 211. doi: 10.1186/s12906-019-2630-5 PMID: 31409331
  5. Huang, C.H.; Chang, H.P.; Su, S.Y.; Chen, W.K.; Chang, Y.J.; Lee, Y.C.; Kuo, Y.J. Traditional Chinese medicine is associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment. J. Ethnopharmacol., 2019, 229, 15-21. doi: 10.1016/j.jep.2018.09.030 PMID: 30261193
  6. Chan, P.W.; Chiu, J.H.; Huang, N.; Chen, C.M.; Yu, H.; Liu, C.Y.; Hsu, C.H. Influence of traditional chinese medicine on medical adherence and outcome in estrogen receptor (+) breast cancer patients in taiwan: A real-world population-based cohort study. Phytomedicine, 2021, 80, 153365. doi: 10.1016/j.phymed.2020.153365 PMID: 33126168
  7. Xiang, Y.; Guo, Z.; Zhu, P.; Chen, J.; Huang, Y. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science. Cancer Med., 2019, 8(5), 1958-1975. doi: 10.1002/cam4.2108 PMID: 30945475
  8. Yan, Z.; Lai, Z.; Lin, J. Anticancer Properties of Traditional Chinese Medicine. Comb. Chem. High Throughput Screen., 2017, 20(5), 423-429. doi: 10.2174/1386207320666170116141818 PMID: 28093974
  9. Kalaiarasi, A.; Anusha, C.; Sankar, R.; Rajasekaran, S.; John Marshal, J.; Muthusamy, K.; Ravikumar, V. Plant Isoquinoline Alkaloid Berberine Exhibits Chromatin Remodeling by Modulation of Histone Deacetylase To Induce Growth Arrest and Apoptosis in the A549 Cell Line. J. Agric. Food Chem., 2016, 64(50), 9542-9550. doi: 10.1021/acs.jafc.6b04453 PMID: 27936791
  10. Chandrashekar, N.; Pandi, A. Baicalein: A review on its anti‐cancer effects and mechanisms in lung carcinoma. J. Food Biochem., 2022, 46(9), e14230. doi: 10.1111/jfbc.14230 PMID: 35543192
  11. Zhang, H.; Zhou, F.; Wang, Y.; Xie, H.; Luo, S.; Meng, L.; Su, B.; Ye, Y.; Wu, K.; Xu, Y.; Gong, X. Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by Dihydroartemisinin Through Abrogating Immunity Escaping and Promoting Radiation Sensitivity by Inhibiting PD-L1 Expression. Front. Oncol., 2020, 10, 595466. doi: 10.3389/fonc.2020.595466 PMID: 33194761
  12. Xu, J.; Pan, Y.; Liu, Y.; Na, S.; Zhou, H.; Li, L.; Chen, F.; Song, H. A review of anti-tumour effects of ginsenoside in gastrointestinal cancer. J. Pharm. Pharmacol., 2021, 73(10), 1292-1301. doi: 10.1093/jpp/rgab048 PMID: 33836068
  13. Chen, Q.; Rahman, K.; Wang, S.J.; Zhou, S.; Zhang, H. Scutellaria barbata: A review on chemical constituents, pharmacological activities and clinical applications. Curr. Pharm. Des., 2020, 26(1), 160-175. doi: 10.2174/1381612825666191216124310 PMID: 31840605
  14. Chen, R.; He, J.; Tong, X.; Tang, L.; Liu, M. The hedyotis diffusa willd. (Rubiaceae): A review on phytochemistry, pharmacology, quality control and pharmacokinetics. Molecules, 2016, 21(6), 710. doi: 10.3390/molecules21060710 PMID: 27248992
  15. Yeh, Y.C.; Chen, H.Y.; Yang, S.H.; Lin, Y.H.; Chiu, J.H.; Lin, Y.H. Hedyotis diffusa combined with scutellaria barbata are the core treatment of chinese herbal medicine used for breast cancer patients: A population-based study. Evid. Based Complement. Alternat. Med., 2014, 2014, 202378. doi: 10.1155/2014/202378 PMID: 24734104
  16. Pan, L.T.; Sheung, Y.; Guo, W.P.; Rong, Z.B.; Cai, Z.M. Hedyotis diffusa plus Scutellaria barbata Induce Bladder Cancer Cell Apoptosis by Inhibiting Akt Signaling Pathway through Downregulating miR-155 Expression. Evid. Based Complement. Alternat. Med., 2016, 2016, 9174903. doi: 10.1155/2016/9174903 PMID: 26989427
  17. Fang, T.; Yan, Y.X.; Yang, Y.; Lv, Y.X.; Chang, Q.Q.; Zhang, D.D. Ethyl Acetate Fraction from Hedyotis diffusa plus Scutellaria barbata Suppresses Migration of Bone-Metastatic Breast Cancer Cells via OPN-FAK/ERK/NF- κ B Axis. Evid. Based Complement. Alternat. Med., 2020, 2020, 3573240. doi: 10.1155/2020/3573240 PMID: 32351594
  18. Yang, Y.; Fang, T.; Cao, Y.L.; Lv, Y.X.; Chang, Q.Q.; Zhang, D.D. Ethyl Acetate Fraction from Hedyotis diffusa plus Scutellaria barbata Exerts Anti-Breast Cancer Effect via miR-200c-PDE7B/PD-L1-AKT/MAPK Axis. Evid. Based Complement. Alternat. Med., 2020, 2020, 3587095. doi: 10.1155/2020/3587095 PMID: 32922506
  19. Ma, T.T.; Zhang, G.L.; Dai, C.F.; Zhang, B.R.; Cao, K.X.; Wang, C.G.; Yang, G.W.; Wang, X.M. Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment: Potential mechanism based on network pharmacology. J. Ethnopharmacol., 2020, 259, 112929. doi: 10.1016/j.jep.2020.112929 PMID: 32416245
  20. Sharma, V.R.; Gupta, G.K.; Sharma, A.K.; Batra, N.; Sharma, D.K.; Joshi, A.; Sharma, A.K. PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation. Curr. Pharm. Des., 2017, 23(11), 1633-1638. doi: 10.2174/1381612823666161116125218 PMID: 27848885
  21. Hua, H.; Kong, Q.; Zhang, H.; Wang, J.; Luo, T.; Jiang, Y. Targeting mTOR for cancer therapy. J. Hematol. Oncol., 2019, 12(1), 71. doi: 10.1186/s13045-019-0754-1 PMID: 31277692
  22. Song, M.; Bode, A.M.; Dong, Z.; Lee, M.H. AKT as a Therapeutic Target for Cancer. Cancer Res., 2019, 79(6), 1019-1031. doi: 10.1158/0008-5472.CAN-18-2738 PMID: 30808672
  23. Matthews, J.M.; Lester, K.; Joseph, S.; Curtis, D.J. LIM-domain-only proteins in cancer. Nat. Rev. Cancer, 2013, 13(2), 111-122. doi: 10.1038/nrc3418 PMID: 23303138
  24. Gerby, B.; Tremblay, C.S.; Tremblay, M.; Rojas-Sutterlin, S.; Herblot, S.; Hébert, J.; Sauvageau, G.; Lemieux, S.; Lécuyer, E.; Veiga, D.F.T.; Hoang, T. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells. PLoS Genet., 2014, 10(12), e1004768. doi: 10.1371/journal.pgen.1004768 PMID: 25522233
  25. Zhu, S.; Zhang, X.; Weichert-Leahey, N.; Dong, Z.; Zhang, C.; Lopez, G.; Tao, T.; He, S.; Wood, A.C.; Oldridge, D.; Ung, C.Y.; van Ree, J.H.; Khan, A.; Salazar, B.M.; Lummertz da Rocha, E.; Zimmerman, M.W.; Guo, F.; Cao, H.; Hou, X.; Weroha, S.J.; Perez-Atayde, A.R.; Neuberg, D.S.; Meves, A.; McNiven, M.A.; van Deursen, J.M.; Li, H.; Maris, J.M.; Look, A.T. LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis. Cancer Cell, 2017, 32(3), 310-323.e5. doi: 10.1016/j.ccell.2017.08.002 PMID: 28867147
  26. Du, L.; Zhao, Z.; Suraokar, M.; Shelton, S.S.; Ma, X.; Hsiao, T.H.; Minna, J.D.; Wistuba, I.; Pertsemlidis, A. LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget, 2018, 9(51), 29601-29618. doi: 10.18632/oncotarget.25642 PMID: 30038707
  27. Wang, K.; Diskin, S.J.; Zhang, H.; Attiyeh, E.F.; Winter, C.; Hou, C.; Schnepp, R.W.; Diamond, M.; Bosse, K.; Mayes, P.A.; Glessner, J.; Kim, C.; Frackelton, E.; Garris, M.; Wang, Q.; Glaberson, W.; Chiavacci, R. Le Nguyen; Jagannathan, J.; Saeki, N.; Sasaki, H.; Grant, S.F.A.; Iolascon, A.; Mosse, Y.P.; Cole, K.A.; Li, H.; Devoto, M.; McGrady, P.W.; London, W.B.; Capasso, M.; Rahman, N.; Hakonarson, H.; Maris, J.M. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature, 2011, 469(7329), 216-220. doi: 10.1038/nature09609 PMID: 21124317

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2024